Sign in

NCT07005453Recruiting

Accuracy and Sustainability of SCALE-EYE Evaluation for Measuring Reliable Polyp Size

Diagnostic Performance and Sustainability of Using SCALE-EYE During Real-Time Colonoscopy

Source: ClinicalTrials.gov · Last updated 13 Jan 2026

Brief summary (registry, in English)

A multicenter, randomized, parallel group, endoscopist blinded study to assess the diagnostic performance and sustainability of SCALE-EYE in a screening and surveillance colonoscopy population. Sustainability will be evaluated in terms of the reduction in colonoscopies, associated waste and carbon footprint.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
241 (estimated)
First submitted
1 May 2025
Start date
23 Sept 2025
Primary completion date
1 Feb 2026
Lead sponsor
Erasmus Medical Center
NCT number
NCT07005453

What you commit to

  • Study type: Interventional
  • Planned participants: 241
  • From 23 Sept 2025 to the primary completion date, 1 Feb 2026
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Known or suspected inflammatory bowel disease (IBD)
  • Polyposis syndromes (e.g. serrated polyposis, familial adenomatous polyposis)
  • History of radiation or chemotherapy for colorectal lesions
  • Scheduled for therapeutic procedure (for example intervention to stop a lower gastro-intestinal bleeding, endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD))

Other

  • No detected colorectal polyps or only diminutive (≤5 mm) hyperplastic rectal polyps are present
  • Inadequate bowel preparation (Boston Bowel Preparation Score (BBPS) \<2 per segment)
  • Intraprocedural complications, not caused by the study device
  • Ileoanal pouch and anastomosis
  • Pregnancy
  • No Informed consent (IC) possible

Who the study is looking for

  • Participants aged 55-80
  • Scheduled for fecal immunochemical test (FIT) screening or surveillance colonoscopy
  • Polyps of all forms ≤25 mm as assessed by the endoscopist

Age in the registry: 55 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Catharina Ziekenhuis
Coordinator of this site? Confirm its status
EindhovenNetherlandsRecruiting
LUMC
Coordinator of this site? Confirm its status
LeidenNetherlandsRecruiting
Erasmus MC
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.